115 related articles for article (PubMed ID: 21360085)
1. A rapid and robust assay for the determination of the amino acid hypusine as a possible biomarker for a high-throughput screening of antimalarials and for the diagnosis and therapy of different diseases.
Kaiser A; Khomutov AR; Simonian A; Agostinelli E
Amino Acids; 2012 May; 42(5):1651-9. PubMed ID: 21360085
[TBL] [Abstract][Full Text] [Related]
2. Chemical profiling of deoxyhypusine hydroxylase inhibitors for antimalarial therapy.
von Koschitzky I; Kaiser A
Amino Acids; 2013 Nov; 45(5):1047-53. PubMed ID: 23943044
[TBL] [Abstract][Full Text] [Related]
3. Production of active recombinant eIF5A: reconstitution in E.coli of eukaryotic hypusine modification of eIF5A by its coexpression with modifying enzymes.
Park JH; Dias CA; Lee SB; Valentini SR; Sokabe M; Fraser CS; Park MH
Protein Eng Des Sel; 2011 Mar; 24(3):301-9. PubMed ID: 21131325
[TBL] [Abstract][Full Text] [Related]
4. Completing the hypusine pathway in Plasmodium.
Frommholz D; Kusch P; Blavid R; Scheer H; Tu JM; Marcus K; Zhao KH; Atemnkeng V; Marciniak J; Kaiser AE
FEBS J; 2009 Oct; 276(20):5881-91. PubMed ID: 19740108
[TBL] [Abstract][Full Text] [Related]
5. Posttranslational synthesis of hypusine: evolutionary progression and specificity of the hypusine modification.
Wolff EC; Kang KR; Kim YS; Park MH
Amino Acids; 2007 Aug; 33(2):341-50. PubMed ID: 17476569
[TBL] [Abstract][Full Text] [Related]
6. The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A).
Park MH
J Biochem; 2006 Feb; 139(2):161-9. PubMed ID: 16452303
[TBL] [Abstract][Full Text] [Related]
7. Assessment of deoxyhypusine hydroxylase as a putative, novel drug target.
Kerscher B; Nzukou E; Kaiser A
Amino Acids; 2010 Feb; 38(2):471-7. PubMed ID: 19956997
[TBL] [Abstract][Full Text] [Related]
8. Post-translational formation of hypusine in eIF5A: implications in human neurodevelopment.
Park MH; Kar RK; Banka S; Ziegler A; Chung WK
Amino Acids; 2022 Apr; 54(4):485-499. PubMed ID: 34273022
[TBL] [Abstract][Full Text] [Related]
9. New insights into novel inhibitors against deoxyhypusine hydroxylase from plasmodium falciparum: compounds with an iron chelating potential.
von Koschitzky I; Gerhardt H; Lämmerhofer M; Kohout M; Gehringer M; Laufer S; Pink M; Schmitz-Spanke S; Strube C; Kaiser A
Amino Acids; 2015 Jun; 47(6):1155-66. PubMed ID: 25715757
[TBL] [Abstract][Full Text] [Related]
10. Neuron-specific ablation of eIF5A or deoxyhypusine synthase leads to impairments in growth, viability, neurodevelopment, and cognitive functions in mice.
Kar RK; Hanner AS; Starost MF; Springer D; Mastracci TL; Mirmira RG; Park MH
J Biol Chem; 2021 Nov; 297(5):101333. PubMed ID: 34688659
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning, expression, and structural prediction of deoxyhypusine hydroxylase: a HEAT-repeat-containing metalloenzyme.
Park JH; Aravind L; Wolff EC; Kaevel J; Kim YS; Park MH
Proc Natl Acad Sci U S A; 2006 Jan; 103(1):51-6. PubMed ID: 16371467
[TBL] [Abstract][Full Text] [Related]
12. Investigation of an Allosteric Deoxyhypusine Synthase Inhibitor in
Aroonsri A; Wongsombat C; Shaw P; Franke S; Przyborski J; Kaiser A
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458660
[TBL] [Abstract][Full Text] [Related]
13. Specificity of the deoxyhypusine hydroxylase-eukaryotic translation initiation factor (eIF5A) interaction: identification of amino acid residues of the enzyme required for binding of its substrate, deoxyhypusine-containing eIF5A.
Kang KR; Kim YS; Wolff EC; Park MH
J Biol Chem; 2007 Mar; 282(11):8300-8. PubMed ID: 17213197
[TBL] [Abstract][Full Text] [Related]
14. Higher activity of recombinant bovine deoxyhypusine synthase vs. human deoxyhypusine synthase.
Huang JK; Tsai S; Huang GH; Gowda PG; Walzer AM; Wen L
Protein Expr Purif; 2004 May; 35(1):32-8. PubMed ID: 15039063
[TBL] [Abstract][Full Text] [Related]
15. Targeting the polyamine-hypusine circuit for the prevention and treatment of cancer.
Nakanishi S; Cleveland JL
Amino Acids; 2016 Oct; 48(10):2353-62. PubMed ID: 27357307
[TBL] [Abstract][Full Text] [Related]
16. A unique modification of the eukaryotic initiation factor 5A shows the presence of the complete hypusine pathway in Leishmania donovani.
Chawla B; Kumar RR; Tyagi N; Subramanian G; Srinivasan N; Park MH; Madhubala R
PLoS One; 2012; 7(3):e33138. PubMed ID: 22438895
[TBL] [Abstract][Full Text] [Related]
17. Recessive Rare Variants in Deoxyhypusine Synthase, an Enzyme Involved in the Synthesis of Hypusine, Are Associated with a Neurodevelopmental Disorder.
Ganapathi M; Padgett LR; Yamada K; Devinsky O; Willaert R; Person R; Au PB; Tagoe J; McDonald M; Karlowicz D; Wolf B; Lee J; Shen Y; Okur V; Deng L; LeDuc CA; Wang J; Hanner A; Mirmira RG; Park MH; Mastracci TL; Chung WK
Am J Hum Genet; 2019 Feb; 104(2):287-298. PubMed ID: 30661771
[TBL] [Abstract][Full Text] [Related]
18. Biological Relevance and Therapeutic Potential of the Hypusine Modification System.
Pällmann N; Braig M; Sievert H; Preukschas M; Hermans-Borgmeyer I; Schweizer M; Nagel CH; Neumann M; Wild P; Haralambieva E; Hagel C; Bokemeyer C; Hauber J; Balabanov S
J Biol Chem; 2015 Jul; 290(30):18343-60. PubMed ID: 26037925
[TBL] [Abstract][Full Text] [Related]
19. Target evaluation of deoxyhypusine synthase from Theileria parva the neglected animal parasite and its relationship to Plasmodium.
Njuguna JT; von Koschitzky I; Gerhardt H; Lämmerhofer M; Choucry A; Pink M; Schmitz-Spahnke S; Bakheit MA; Strube C; Kaiser A
Bioorg Med Chem; 2014 Aug; 22(15):4338-46. PubMed ID: 24909679
[TBL] [Abstract][Full Text] [Related]
20. Assay of deoxyhypusine hydroxylase activity.
Park JH; Wolff EC; Park MH
Methods Mol Biol; 2011; 720():207-16. PubMed ID: 21318876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
